Dharti Proteins reports net loss of ₹84.65 lakh in FY26
May 30, 2026
Dharti Proteins Limited reported a net loss of ₹84.65 lakh for FY26, compared to a loss of ₹0.67 lakh in FY25, following an NCLT-approved resolution plan. Revenue from operations was nil, while total expenses rose to ₹17.61 lakh. The resolution plan led to a significant restructuring of equity share capital, reducing it to ₹50 lakh from ₹1,027.72 lakh.
Dharti Proteins Limited reported a net loss of ₹84.65 lakh for the financial year ended March 31, 2026, following the implementation of a resolution plan approved by the National Company Law Tribunal (NCLT). The company's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, at a meeting held on May 29, 2026. The statutory auditors, M/s. N. S. Nanavati & Co., issued an unmodified opinion on the results, though they drew attention to the extinguishment of liabilities and restructuring of equity pursuant to the resolution plan.
Financial Performance
The company recorded zero revenue from operations for the quarter and year ended March 31, 2026. Total revenue stood at ₹0.04 lakh for the quarter and ₹2.97 lakh for the year, derived solely from other income. Total expenses for the year were ₹17.61 lakh, up from ₹7.87 lakh in the previous year. The company reported an exceptional item of ₹70.01 lakh for the year, primarily relating to the waiver and extinguishment of liabilities under the resolution plan. Consequently, the profit for the period from continuing operations was a loss of ₹84.65 lakh for FY26, compared to a loss of ₹0.67 lakh in FY25.
Key Financial Metrics
Metric FY26 (₹ in Lakhs) FY25 (₹ in Lakhs) Total Revenue 2.97 7.20 Total Expenses 17.61 7.87 Profit for the Period (84.65) (0.67) Basic EPS (16.93) (0.01)
Resolution Plan Impact
The financial results reflect the impact of the resolution plan approved by the Hon'ble NCLT, Ahmedabad Bench, on November 18, 2025. Pursuant to the plan, the company's paid-up equity share capital was restructured, involving the cancellation of existing shares and the issuance of fresh equity. The public shareholding was reduced to 25,000 equity shares, while 50,000 equity shares were allotted to Financial Creditors and 4,25,000 equity shares were allotted to the Successful Resolution Applicant and its group of promoters. As a result, the paid-up equity share capital as of March 31, 2026, stood at ₹50 lakh, compared to ₹1,027.72 lakh in the previous year.
Balance Sheet and Cash Flows
The company's total assets decreased to ₹72.30 lakh as of March 31, 2026, from ₹670.06 lakh in the prior year, largely due to the write-off of receivables and other assets. Total equity turned negative at ₹263.62 lakh. Cash and cash equivalents decreased significantly to ₹3.29 lakh from ₹129.90 lakh, primarily due to cash used in operations. The net cash outflow from operating activities was ₹470.10 lakh, while investing activities provided a net inflow of ₹311.80 lakh, mainly from investments in fixed deposits.
Dharti Proteins Limited has filed its Thirty-First Annual Report for the financial year 2024-25 with the Bombay Stock Exchange. The communication, dated May 13, 2026, clarifies that the company had undergone the Corporate Insolvency Resolution Process (CIRP) and was subsequently revived following an order by the National Company Law Tribunal, Ahmedabad Bench, on November 18, 2025. The new management took over the company's affairs on December 19, 2025, and has since focused on stabilizing operations and regularizing compliance.
Financial Performance
The company reported a net loss of ₹0.66 lakh for the year ended March 31, 2025, compared to a net loss of ₹19.01 lakh in the previous year. Income from operations remained nil for both years, while other income stood at ₹7.20 lakh for 2024-25 against nil in the prior year. Total expenditure for the year was ₹7.87 lakh, down from ₹19.01 lakh in 2023-24. The basic and diluted earnings per share (EPS) for the year was reported at (0.01), an improvement from (0.18) in the previous year.
Particulars 2024-25 (₹ in Lakhs) 2023-24 (₹ in Lakhs) Income from Operations Nil Nil Other Income 7.20 Nil Total Expenditure 7.87 19.01 Profit/(Loss) Before Tax (0.66) (19.01) Net Profit/(Loss) After Tax (0.66) (19.01) Basic and Diluted EPS (0.01) (0.18)
Auditor's Observations
The Independent Auditor’s Report issued by N.S. Nanavati & Co. carries a qualified opinion. The auditors noted that the company has been inoperative for several years with no trading or manufacturing activities. They highlighted substantial doubt regarding the company's ability to continue as a going concern due to negative financial indicators and the absence of formal financial support. Additionally, the report cited non-compliance with the maintenance of accounting software audit trails and outstanding statutory dues, including income tax and sales tax amounts pending for more than six months.
Compliance and Governance
The company stated that the delay in filing the annual report was due to the circumstances prevailing during the CIRP period and the subsequent transition. The present management has taken steps to complete the requisite compliance as a measure of good corporate governance. The company remains committed to adhering to all statutory and regulatory requirements and strengthening its compliance framework going forward.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.
Financial Performance
The company recorded zero revenue from operations for the quarter and year ended March 31, 2026. Total revenue stood at ₹0.04 lakh for the quarter and ₹2.97 lakh for the year, derived solely from other income. Total expenses for the year were ₹17.61 lakh, up from ₹7.87 lakh in the previous year. The company reported an exceptional item of ₹70.01 lakh for the year, primarily relating to the waiver and extinguishment of liabilities under the resolution plan. Consequently, the profit for the period from continuing operations was a loss of ₹84.65 lakh for FY26, compared to a loss of ₹0.67 lakh in FY25.
Key Financial Metrics
Metric FY26 (₹ in Lakhs) FY25 (₹ in Lakhs) Total Revenue 2.97 7.20 Total Expenses 17.61 7.87 Profit for the Period (84.65) (0.67) Basic EPS (16.93) (0.01)
Resolution Plan Impact
The financial results reflect the impact of the resolution plan approved by the Hon'ble NCLT, Ahmedabad Bench, on November 18, 2025. Pursuant to the plan, the company's paid-up equity share capital was restructured, involving the cancellation of existing shares and the issuance of fresh equity. The public shareholding was reduced to 25,000 equity shares, while 50,000 equity shares were allotted to Financial Creditors and 4,25,000 equity shares were allotted to the Successful Resolution Applicant and its group of promoters. As a result, the paid-up equity share capital as of March 31, 2026, stood at ₹50 lakh, compared to ₹1,027.72 lakh in the previous year.
Balance Sheet and Cash Flows
The company's total assets decreased to ₹72.30 lakh as of March 31, 2026, from ₹670.06 lakh in the prior year, largely due to the write-off of receivables and other assets. Total equity turned negative at ₹263.62 lakh. Cash and cash equivalents decreased significantly to ₹3.29 lakh from ₹129.90 lakh, primarily due to cash used in operations. The net cash outflow from operating activities was ₹470.10 lakh, while investing activities provided a net inflow of ₹311.80 lakh, mainly from investments in fixed deposits.
Dharti Proteins Limited has filed its Thirty-First Annual Report for the financial year 2024-25 with the Bombay Stock Exchange. The communication, dated May 13, 2026, clarifies that the company had undergone the Corporate Insolvency Resolution Process (CIRP) and was subsequently revived following an order by the National Company Law Tribunal, Ahmedabad Bench, on November 18, 2025. The new management took over the company's affairs on December 19, 2025, and has since focused on stabilizing operations and regularizing compliance.
Financial Performance
The company reported a net loss of ₹0.66 lakh for the year ended March 31, 2025, compared to a net loss of ₹19.01 lakh in the previous year. Income from operations remained nil for both years, while other income stood at ₹7.20 lakh for 2024-25 against nil in the prior year. Total expenditure for the year was ₹7.87 lakh, down from ₹19.01 lakh in 2023-24. The basic and diluted earnings per share (EPS) for the year was reported at (0.01), an improvement from (0.18) in the previous year.
Particulars 2024-25 (₹ in Lakhs) 2023-24 (₹ in Lakhs) Income from Operations Nil Nil Other Income 7.20 Nil Total Expenditure 7.87 19.01 Profit/(Loss) Before Tax (0.66) (19.01) Net Profit/(Loss) After Tax (0.66) (19.01) Basic and Diluted EPS (0.01) (0.18)
Auditor's Observations
The Independent Auditor’s Report issued by N.S. Nanavati & Co. carries a qualified opinion. The auditors noted that the company has been inoperative for several years with no trading or manufacturing activities. They highlighted substantial doubt regarding the company's ability to continue as a going concern due to negative financial indicators and the absence of formal financial support. Additionally, the report cited non-compliance with the maintenance of accounting software audit trails and outstanding statutory dues, including income tax and sales tax amounts pending for more than six months.
Compliance and Governance
The company stated that the delay in filing the annual report was due to the circumstances prevailing during the CIRP period and the subsequent transition. The present management has taken steps to complete the requisite compliance as a measure of good corporate governance. The company remains committed to adhering to all statutory and regulatory requirements and strengthening its compliance framework going forward.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.